Hydronephrosis Market is Expected to Grow at a CAGR of 12.2% From 2022 To 2030

Pune, India, September, 2022/MRFR Press Release/- Market Research Future has a cooked research report on the global hydronephrosis market. 

Market HighlightsThe global hydronephrosis market is expected to show sharp growth over the forecast period. Increasing prevalence of kidney diseases and demand for diagnostics services in the field of nephrology are the key factor for the market growth. Rising geriatric population with chronic diseases affecting the kidney and increasing demand for advanced treatment measures also drive the market growth.

The Hydronephrosis Market is expected to reach USD 388.4 Million by 2030 at 12.2% CAGR during the forecast period 2022 -2030

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “hydronephrosis market research report–Global forecast till 2030.”

Major Players in Hydronephrosis MarketSome of the key players in the global market are NephroGenex, Inc. (U.S), American Renal Associates (U.S), PHRAXIS, INC. (U.S), Renal Associates P.A. (U.S), ALLERGAN (U.S), Amgen Inc. (U.S), Anthem Bio Pharm (U.S), Sanofi (U.S), and Novartis AG (Germany)  

Regional Analysis

The global hydronephrosis market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global hydronephrosis market. It comprises of two regions namely North America and South America. North America is the largest market owing to extensive use of advanced diagnostics services and development of new drugs by leading market players for the treatment of hydronephrosis.

In the Europe, increasing adoption of new diagnostics techniques, increasing awareness about congenital anomalies, and overall development of healthcare sector contribute to the market growth.

Asia Pacific is the fastest growing and potential market for the hydronephrosis treatment, whose growth is attributed to the rising concerns over reproductive health of women and rising prevalence of hydronephrosis in the new born.

The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as diagnosis and medical devices.

SegmentationThe global hydronephrosis market is segmented on the basis of types, which includes unilateral and bilateral hydronephrosis.

On the basis of diagnosis, the market is segmented into laboratory test and imaging. Laboratory test is further sub-segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.

On the basis of treatment, the market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.

On the basis of indication, the market is segmented into intrinsic and extrinsic causes of hydronephrosis. Intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. Extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Hydronephrosis Market Research Report